Walter B, Tamm D
Med Klin. 1979 Feb 16;74(7):239-41.
Deep femoral and pelvic phlebothrombosis represents a safe indication for thrombolytic therapy, despite the fact that additionally considered surgical measures have increasingly been brought up for discussion very recently. While numerous studies are being considered for treatment with streptokinase, only sporadically does one hear of reports about therapy using Urokinase. In the case of a deep pelvo-femoral phlebothrombosis we decided to carry out thrombolytic treatment using Urokinase, the originally planned streptokinase treatment having had to be terminated owing to an allergic reaction.
尽管最近越来越多地提出了额外的手术措施供讨论,但股深部和盆腔静脉血栓形成仍是溶栓治疗的安全指征。虽然目前有许多关于链激酶治疗的研究,但关于使用尿激酶治疗的报道却很少。对于一例深部盆腔-股静脉血栓形成患者,我们决定采用尿激酶进行溶栓治疗,原计划的链激酶治疗因过敏反应而不得不终止。